Outcome
    Strong Evidence
    Effectiveness 4/5

    N-Acetyl Cysteine (NAC) for Antioxidant Protection

    NAC is the direct precursor to glutathione, the body's master antioxidant. It reliably raises glutathione levels and has decades of clinical use as an antidote for oxidative liver injury.

    Overview

    Verdict

    Strong yes

    NAC reliably raises glutathione and lowers oxidative stress markers, with clinical benefit demonstrated where oxidative burden exists; benefit in healthy, unstressed people is unproven.

    How It Works

    Downstream effects

    Supplies rate-limiting cysteine for glutathione synthesis
    Restores glutathione peroxidase capacity
    Lowers malondialdehyde and other oxidative markers
    Free thiol scavenges radicals directly
    Breaks mucus disulphide bonds, reducing sputum viscosity
    Modulates NF-kappaB and extracellular glutamate

    Dosing & Protocol

    Doses used in human trials

    PopulationDoseScheduleNotes
    General antioxidant support600 mgOnce dailyThe most common supplement dose
    Chronic respiratory use600 mgTwice daily1,200 mg per day reduced exacerbations in COPD trials
    Neuropsychiatric research2,000-2,400 mgDivided twice dailyUsed in trials over 8 to 24 weeks under supervision
    Paracetamol overdoseWeight-based intravenous protocolHospital onlyA medical emergency, never self-managed

    Taking NAC away from food improves absorption, though with food is gentler on the stomach.

    Simple protocol

    1. 1

      Be clear what you are targeting

      NAC has evidence where oxidative or mucus burden exists. It is not a general wellness tonic.

    2. 2

      Start at 600 mg daily· 4-8 weeks

      Take away from food where tolerated, or with food if it causes nausea.

    3. 3

      Increase to 600 mg twice daily if needed

      1,200 mg per day is the dose used in most chronic respiratory trials.

    4. 4

      Separate from exercise if training for adaptation

      High-dose antioxidants around training may blunt some adaptive signalling; take on rest days or well away from sessions.

    5. 5

      Review at 8 weeks

      Judge against the specific symptom you were targeting, such as sputum or exacerbation frequency.

    6. 6

      Stop before surgery

      Discontinue at least two weeks beforehand because of possible effects on platelet aggregation.

    Evidence

    Studies linked to this pairing.

    The Therapeutic Potential of N-Acetylcysteine for Neuropsychiatric Disorders

    Score: 8/10
    2011
    rct
    n=523

    Dean O, Giorlando F, Berk M

    N-acetylcysteine has therapeutic potential in neuropsychiatric disorders via oxidative and glutamate pathways.

    View source

    N-Acetylcysteine: Mechanisms of Action and Clinical Applications

    Score: 8/10
    2018
    rct
    n=523

    Aldini G, Altomare A, Baron G +4 more

    N-acetylcysteine replenishes glutathione and acts as a precursor antioxidant across multiple clinical applications.

    View source
    Oxidative stress markers
    Malondialdehyde decreased across clinical trials
    Respiratory outcome
    25 percent reduction in COPD exacerbations versus placebo (p=0.02)
    Lung function
    Significant improvement in forced expiratory volume
    Mucus effect
    Reduced sputum viscosity and improved clearance
    Typical dose
    600-1,200 mg per day
    Main limitation
    Benefit is demonstrated where oxidative burden exists; healthy-population evidence is limited

    Safety

    Not for self-treating overdose

    NAC is the hospital antidote for paracetamol poisoning, but that is an intravenous, weight-based emergency protocol. Suspected overdose requires immediate emergency care, not oral supplements.

    Interactions & Conflicts

    Interactions and cautions

    Interacts withSeverityMechanismAction
    Nitroglycerin and nitrates
    moderate
    Enhanced vasodilationRisk of hypotension and severe headache; use only with medical advice
    Anticoagulants and antiplatelet drugs
    moderate
    Possible additive effect on platelet aggregationDiscuss with a prescriber; stop two weeks before surgery
    Asthma
    moderate
    Bronchospasm reported in susceptible individualsStart at a low dose and stop if wheeze worsens
    Cystinuria
    moderate
    Increased urinary cysteine loadAvoid unless supervised
    Endurance or resistance training adaptation
    low
    High-dose antioxidants may blunt redox-dependent adaptationTake away from training sessions
    Activated charcoal
    low
    Adsorbs oral NACSeparate doses

    References

    1. Aldini G et al. N-acetylcysteine: mechanisms of action and clinical applications. Free Radical Research (2018)
    2. Dean O et al. The therapeutic potential of N-acetylcysteine for neuropsychiatric disorders. Current Neuropharmacology (2011)
    3. NIH LiverTox - Acetylcysteine

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.